Biological Information

Background Information:

Smurf1 is a HECT-type ubiquitin ligase that regulates multiple biological networks including TGFB1 (transforming growth factor beta 1) and BMP signalling pathways, the Toll-like receptor pathway, and the mitogen-activated protein kinase pathway. Smurf1 overexpression promotes tumorigenesis across multiple cancers by driving ubiquitin-mediated degradation of tumor suppressors and activating oncogenic signalling. In cervical and ovarian cancers, Smurf1 targets RhoB and ARHGAP26, respectively, enhancing invasion and metastasis via beta-catenin signaling. In breast cancer, Smurf1 facilitates estrogen receptor-alpha signaling required for estrogen-dependent tumor growth. Elevated Smurf1 expression is also linked to brain tumor malignancy, correlating with glioma grade, while its knockdown has been shown to suppress glioblastoma progression, partly through effects on PTEN. Collectively, Smurf1’s oncogenic activity is closely associated with activation of the PI3K/AKT pathway, and its suppression inhibits cancer progression in multiple tumor types.

Target Class:

Ubiquitination-related

Family:

SMURF

Sub Family:

E3 Ligase

Protein Name:

Smurf1

Protein Aliases:

hSMURF1

Accession Number:

NM_181349.2

UniProt Number:

Q9HCE7

Gene Name:

SMURF1

Gene ID:

57154

Target Species:

Human

Usage

Product Type:

Enzymes

Application:

Drug Discovery & Development

Storage Conditions:

1 year at -70°C

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Enzymatic

Assay Measures:

ECL

Bioassay Data

Trademark Statement:

For Research Use Only

Clinical Relevance

Therapeutic Area:

Oncology